XP-005
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XP-005, covering 2025-05-20 to 2025-05-20. Get the full timeline:
Most recent: Clinical Trial Update: XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia [EARLY_Phase 1]